ShangBay Capital's book
32 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Noah Medical | — | $2.0B | — | — | |
| Abcuro | Drug Discovery | $700.0M | — | — | |
| SetPoint Medical | Therapeutic Devices | $480.0M | — | — | |
| Neptune Medical | — | $387.0M | — | — | |
| Inquis Medical | — | $375.0M | — | — | |
| Alleviant Medical | — | $260.0M | — | — | |
| Mediar Therapeutics | — | $230.0M | — | — | |
| Emboline | — | $151.4M | — | — | |
| Aveta System | — | $150.0M | — | — | |
| Neuro42 | — | $135.0M | — | — | |
| + 22 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 32 recorded positions
- ·Every recorded deal — 1 rounds
- ·Watchlist + alerts for ShangBay Capital's activity
Create free account
No card required